BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gurumoorthy N, Nordin F, Tye GJ, Wan Kamarul Zaman WS, Ng MH. Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through. Biomedicines 2022;10:107. [DOI: 10.3390/biomedicines10010107] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Hussein M, Molina MA, Berkhout B, Herrera-Carrillo E. A CRISPR-Cas Cure for HIV/AIDS. Int J Mol Sci 2023;24. [PMID: 36675077 DOI: 10.3390/ijms24021563] [Reference Citation Analysis]
2 Mohammadian Gol T, Ureña-Bailén G, Hou Y, Sinn R, Antony JS, Handgretinger R, Mezger M. CRISPR medicine for blood disorders: Progress and challenges in delivery. Front Genome Ed 2022;4:1037290. [PMID: 36687779 DOI: 10.3389/fgeed.2022.1037290] [Reference Citation Analysis]
3 Yang R, Pan J, Wang Y, Xia P, Tai M, Jiang Z, Chen G. Application and prospects of somatic cell reprogramming technology for spinal cord injury treatment. Front Cell Neurosci 2022;16. [DOI: 10.3389/fncel.2022.1005399] [Reference Citation Analysis]
4 Bhattacharjee R, Jana A, Nandi A, Sinha A, Bhattacharjee A, Mitra S, Kar S, Dey A, Kumar Singh S, Rajender Varma S, Kumar Panda P, Suar M, Suresh Verma K. Synergy of Nanocarriers with CRISPR-Cas9 in an Emerging Technology Platform for Biomedical Appliances: Current Insights and Perspectives. Materials & Design 2022. [DOI: 10.1016/j.matdes.2022.111415] [Reference Citation Analysis]
5 Asmamaw Mengstie M. Viral Vectors for the in Vivo Delivery of CRISPR Components: Advances and Challenges. Front Bioeng Biotechnol 2022;10:895713. [DOI: 10.3389/fbioe.2022.895713] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]